Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...

Aptamer Group Plc ( (GB:APTA) ) has provided an update.

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

Senescent “zombie” cells are linked to aging and multiple diseases, but spotting them in living tissue has been notoriously ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

Saga PLC - Kent, England-based provider of products and services for people over 50 - Announces that its 20-year motor and home insurance partnership with Ageas UK, wholly-owned subsidiary of Ageas SA ...

A research group at the Italian Institute of Technology (Istituto Italiano di Tecnologia - IIT) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The ...

When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells - also known as "zombie cells" - stop dividing but don't die off as cells typically ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a ...